Superworth

Eli Lilly and PE ratio LLY

Share price divided by earnings per share over the last twelve months, since 1997.

Today, Nov 3, 2026
46.5×
10-year median
41.6×
Against its 10-year history
55th
percentile: 0 is its lowest day, 100 its highest
10-year range
13.4× to 278×
Peer median
40.9×

Eli Lilly and's PE ratio is 46.5× as of Nov 3, 2026: a share price of $1,432.31 against $30.81 of earnings per share over the last twelve months.

That is above its ten-year median of 41.6×, close to the middle of its last ten years.

Over that time it ranged from 13.4× in Oct 2019 to 278× in Feb 2019.

The median for 6 large drugmakers of a similar size is 40.9×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far45.8×33.7×52.9×
202552.7×40.9×87.7×
202484.7×80.7×142×
2023106×45.7×109×
202254.9×35.9×57.4×
202142.1×27.1×42.1×
202027.6×14.0×28.1×
201916.0×13.4×278×
2018260×36.1×270×
201740.0×31.7×41.0×
201632.0×29.4×37.6×
201538.1×28.0×45.8×
201428.2×11.7×29.0×
201311.7×10.9×15.7×
201213.2×9.3×14.6×
20119.9×7.4×10.0×
20108.0×7.8×9.3×
2009n/m a value too high to mean anything
200817.4×16.8×27.7×
200726.4×24.8×29.7×

Against its peers

Companies in Drug Manufacturers - General nearest Eli Lilly and's size, closest first, today.

CompanyPE ratio
LLYEli Lilly and46.5×
JNJJohnson & Johnson40.9×
ABBVAbbVie49.8×
MRKMerck150×
AMGNAmgen29.0×
GILDGilead Sciencesn/m
PFEPfizer40.6×
Peer median40.9×

Where Eli Lilly and ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Eli Lilly and

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.